Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
SNSE
SNSE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest SNSE ETF News Today | Earnings, Events & Price Alerts
SNSE News
Sensei Biotherapeutics Grants Stock Options to New Employees
Feb 25 2026
Newsfilter
Sensei Biotherapeutics Secures $200 Million Financing and Acquires Faeth
Feb 18 2026
stocktwits
U.S. Stocks Rise, Nasdaq Gains Over 1%
Feb 18 2026
Benzinga
Sensei Biotherapeutics Acquires Faeth Therapeutics for $200M
Feb 18 2026
seekingalpha
U.S. Stocks Rise in Morning Trading, Dow Up Approximately 100 Points
Feb 18 2026
Benzinga
Biotech Stocks Surge: Coherus Up 9.09% in After-Hours Trading
Jan 23 2026
NASDAQ.COM
What Caused Sensei Biotherapeutics (SNSE) Stock to Surge Nearly 63% in After-Hours Trading?
Dec 05 2025
Benzinga
Healthcare and Biotech Stocks Surge in After-Hours Trading: Sensei, Praxis, Cooper, Vanda, Cue, ResMed
Dec 05 2025
NASDAQ.COM
Sensei Biotherapeutics Launches Strategic Review Aimed at Enhancing Shareholder Value
Oct 30 2025
Newsfilter
Post-Market Jump: Turn Therapeutics Soars 134% Following Nasdaq Debut; Biotech Stocks Rise
Oct 09 2025
NASDAQ.COM
HC Wainwright & Co. Maintains Buy on Sensei Biotherapeutics, Raises Price Target to $30
Aug 05 2025
Benzinga
Sensei Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Aug 05 2025
Newsfilter
Sensei Biotherapeutics to Present Clinical Data from the Phase 1 Dose Expansion Cohort of Solnerstotug at the ESMO Congress 2025
Jul 30 2025
Newsfilter
Upcoming Stock Splits This Week (June 16 to June 20) – Stay Invested
Jun 15 2025
TipRanks
Sensei Biotherapeutics to execute 1-for-20 reverse stock split
Jun 13 2025
SeekingAlpha
Sensei Biotherapeutics Reports First Quarter 2025 Financial Results and Updates on Clinical Progress
May 06 2025
Newsfilter
Show More News
